The European Court of Human Rights Against Authoritarian Populism: Why? And How?
European Convention on Human Rights Law Review · 03.11.2025 · 7 (1-2) · 170-211
DOI: 10.1163/26663236-bja10146 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Convention on Human Rights Law Review, erschienen am 03.11.2025. Verfasst von Andreas Follesdal.
Abstract (Originalsprache)
The European Court of Human Rights (ECtHR) may respond in several ways against authoritarian populism. Section 1 addresses the relationship between authoritarian populist practices and ideologies, whilst Section 2 identifies problematic symptoms of authoritarian populist practices. Section 3 sketches three explanations of the growth of authoritarian populism with divergent prescriptions. Section 4 elaborates on the notion of legitimacy, and defends three valuable subsidiary roles of the ECtHR: not as a ‘conscience’, but as a fire alarm, to assure citizens, and to mobilise domestic actors. Section 5 brings this to bear on six stages, drawing on the Inter-American Court of Human Rights and the African Court of Human and People’s Rights: case prioritisation, proceedings, writing judgments, deciding remedies, monitoring compliance, and outreach; utilising the doctrine of margin of appreciation with a proportionality test further.
Zitieren
APA
Follesdal, A. (2025). The European Court of Human Rights Against Authoritarian Populism: Why? And How?. European Convention on Human Rights Law Review, 7(1-2), 170-211. https://doi.org/10.1163/26663236-bja10146
Vancouver
Follesdal A. The European Court of Human Rights Against Authoritarian Populism: Why? And How?. European Convention on Human Rights Law Review. 2025;7(1-2):170-211. doi:10.1163/26663236-bja10146
BibTeX
@article{Follesdal2025,
author = {Follesdal, Andreas},
title = {The European Court of Human Rights Against Authoritarian Populism: Why? And How?},
journal = {European Convention on Human Rights Law Review},
year = {2025},
volume = {7},
number = {1-2},
pages = {170--211},
doi = {10.1163/26663236-bja10146}
}
EUVIMED